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Abstract
Background: Macrophages cover a major role in the immune system, being the most plastic cell yielding several key
immune functions.
Methods: Here we derived a minimalistic gene regulatory network model for the differentiation of macrophages into
the two phenotypes M1 (pro-) and M2 (anti-inflammatory).
Results: To test the model, we simulated a large number of such networks as in a statistical ensemble. In other
words, to enable the inter-cellular crosstalk required to obtain an immune activation in which the macrophage plays
its role, the simulated networks are not taken in isolation but combined with other cellular agents, thus setting up a
discrete minimalistic model of the immune system at the microscopic/intracellular (i.e., genetic regulation) and
mesoscopic/intercellular scale.
Conclusions: We show that within the mesoscopic level description of cellular interaction and cooperation, the gene
regulatory logic is coherent and contributes to the overall dynamics of the ensembles that shows, statistically, the
expected behaviour.
Keywords: Macrophage differentiation, Gene regulatory network, Agent-based modelling, Multiscale modelling
Background
Recently, multiscale modelling - i.e., the integration of
mathematical and computational models of processes
at different spatial, temporal and organisational levels -
earned its way as a growingly relevant resource to address
immunological questions [1], after becoming a valuable
support to examine diverse physiopathological processes
and explore biological complexity [2].
In general, multiscale modeling refers to different mod-
els implemented at different scales of resolution used con-
currently for the description and simulation of a system.
When implemented in the biological field, each model
usually describes mechanisms specific of one spatial
and/or temporal scale, and it is integrated and intertwined
with the other models, describing different scales, by
input/output exchange and feedback.
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Classifying biological processes into discrete levels
can be a helpful yet approximate representation [3].
Such levels are usually categorised into microscopic
(mainly molecular and intracellular events), mesoscopic
(cell-to-cell, host-pathogen events) and macroscopic (tis-
sue/organ/organism) scales [4, 5].
Multiscale immunological models, which fully fall
within the extent of systems biology and computational
system medicine [6], and of the Virtual Physiological
Human initiative [7], can be general purpose models or
also directly focus on a range of pathologies by tailor-
ing themodels on patient-specific immunological profiles,
with the scope to evaluate the efficacy of treatments, and
to enhance therapeutic regimens.
Among immune-specialised cells, the macrophage cov-
ers a paramount role: it is the most plastic cells of the
haematopoietic system, present in all body tissues with
large functional heterogeneity, central for development,
homeostasis, tissue repair and immunity [8]. The work
presented here is in particular aimed at increasing our
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understanding of pro- and anti-inflammatory processes
in which macrophage responses are involved (e.g., cancer,
obesity, arthritis, infectious diseases such as leishmani-
asis, phagocytosis processes, among many others) [8],
and to suggest improved treatments of such widespread
immunological disorders.
On the same track of our previous work aimed at inte-
grating Th1/Th2/Th17/Treg differentiation in an agent-
based immune system model [9], our attempt targets at
integrating the microscopic scale (sensing and processing
of immune mediators, immune signalling and transduc-
tion pathways), here modelled by means of a gene regula-
tory network driving humanmacrophage polarisation into
M1/M2 phenotypes (as better described in the following
paragraph), with the meso- and macroscopic scale, mod-
elled as an individual-based simulation of the immune
system [10].
This article is organised as follows. In the next section
we will give the biological background of the macrophage
maturation and the way we take into account the genetic
circuitry affecting the differentiation state. Then we will
describe how we combined this molecular-level descrip-
tion with the upper-level (i.e., cellular) description of the
main immune rules enacting the immune response. The
resulting “statistical ensemble” is then checked against
patterns observed in real conditions hence demonstrating
the soundness, though essential, rationale of the differen-
tiation network.
Macrophages and their differentiation into the M1 andM2
subtypes
Myelomonocytic cells, derived from bone marrow pre-
cursors, are important components of the immune
system and they can differentiate into macrophages
[11–13]. Macrophages are remarkably versatile in their
ability to recognise and respond to a wide range of
molecules, expressing different surface and intracellular
receptors, signal transduction components, chemokines
and interleukins, and a variety of tryptophan metabolism
pathways. They have potent endocytic, phagocytic, and
secretory functions, able to engage upon contact with
different cell types, such as macrophages themselves,
microorganisms and chemical mediators [14]. Plastic-
ity and diversity have long been known to be features
of the monocyte-macrophage differentiation pathway.
Phagocyte-mediated innate immunity also has a built-in
adaptive component, and the ability to mount a polarised
response is a reflection of this [15–17].
Mirroring T helper type 1 / type 2 (Th1-Th2) polar-
isation, two distinct states of polarised activation for
macrophages have been proposed in the literature: the
classically activated (M1) macrophage phenotype and
the alternatively activated (M2) macrophage phenotype
[18]. M1 macrophages have a typical pro-inflammatory
function, inhibiting cell proliferation and expressing tissue
damage activities, while M2 macrophages have anti-
inflammatory functions, promoting cell proliferation and
tissue repair. M1 macrophages often work together with
Th1 lymphocytes, much as M2 macrophages together
with Th2 lymphocytes, to produce typical immune
responses.
The polarised form of a macrophage can be inferred by
the stimulus that leads the macrophage to its functioning.
A typical inflammatory stimulus derives from interferon
gamma (INF-γ herein also indicated IFNg) produced by
Th1 cells. IFNg is the main cytokine associated with the
M1 polarisation, together with lipopolysaccharide (LPS),
which is a component of Gram-negative bacteria, and the
granulocyte macrophage colony-stimulating factor (GM-
CSF). They can lead to a strong pro-inflammatory pattern
of gene expression, determining the production of IFN-
β , interleukins IL-12, IL-1, IL-1β , tumour necrosis factor
TNF and nitric oxide (NO).
The main stimuli that lead to aM2 polarised form of the
macrophages are those from IL-4, IL-13, IL-10 and gluco-
corticoid hormones. In contrast to M1, M2 macrophages
produce low IL-12 (indicated IL-12lo) and high IL-10
(IL-10hi), with an efficient phagocytic activity and anti-
inflammatory functions.
Gene regulatory networks
Gene regulatory networks modelling has been identified
as a validmean to understand the way cells integrate extra-
cellular stimuli to activate cellular programs such as the
differentiation whereby detailed kinetic information is not
available [19].
The typical study includes the following steps:
1. The most important signal transducers, transcription
factors and target genes proven to be involved in the
activation of a certain cellular program (such as the
differentiation of the macrophage, in our specific
case) are identified and their mutual relationships in
terms of inhibition/activation is derived from
existing literature or experimental data.
2. The resulting information is arranged in a graph, or
network, (N ,E) in which the nodes N are the
molecules and the edges E = E− ∪ E+ are the
relationships (i.e., an activation or enhancement or
upregulation is indicated with an edge in the set E+,
whereas an inhibition is indicated by an edge in E−).
3. A set of values representing the activation level or the
concentration of the gene/molecules in N is given.
For instance the simplest case is the Boolean one in
which 0 indicates low concentration/no activation,
and 1 indicates high concentration or activation. The
multi-valued case is when nk can take up more than
two levels of activation/concentration.
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4. For each node nk ∈ N it is defined the function F(·)
(e.g., a Boolean function F : {0, 1}|N | → {0, 1}N ) of
the incident edges specifying how the state of the
node n at a certain time t is determined by the nodes
nj for which there exists an edge ejk ∈ E. This
identifies the system as a dynamical system in which
each node at time t is updated on the basis of the
values of the nodes at the previous discrete time step.
Once established the network’s Boolean function F(·) ,
the network is studied in terms of its dynamical proper-
ties in particular in the nature and number of steady states
that the dynamics can attain since they are interpreted as
stable patterns of gene expression that characterising the
differentiation fate of the cell.
As for the function F(·), in the present work, we use the
simple map


















eu,v|(v = i) ∧ (eu,v ∈ E+)
}
is the set
of activation arcs incident on node i and E−i ={
eu,v|(v = i) ∧ (eu,v ∈ E−)
}
is the set of inhibition arcs
incident on node i. The function F states that a gene will
become active if anyone of the activation gene is active and
none of the inhibition genes is active. It all other cases the
gene will remain or become inactive.
Aminimalistic view of the regulatory logic of
macrophage differentiation
By following the steps described above, we inferred
the regulatory network that controls the polarisation of
macrophages from experimental data derived from liter-
ature. These data refer to the main molecules involved
in the control of macrophages polarisation into form M1
and M2.
The M1 and M2 states represent cell activation states
polarised by cytokines, initially determined using IFN-γ ,
LPS and IL-4 and IL-10 that are typically secreted by Th1
or Th2 cells, bacteria and B lymphocytes. TheM1 status is
polarised by Th1 cytokines and pro-inflammatory chem-
ical mediators including several pathogen-associated
molecular components. In contrast, M2 status is polarised
by IL-10 and IL-4 [20]. An initial stimulus leads to the acti-
vation of specific transcription factors that mediate the
changes in the target genes expression.
Pro-inflammatory M1 subtype
Both the type 1 IFN (IFN-α and IFN-β) receptors and the
type 2 IFN (IFN-γ ) receptors have multi-chain structures,
which are composed of at least two distinct subunits:
IFNGR1 and IFNGR2 for the type 2 IFN receptor. Each
of these receptor subunits interacts with a member of
the Janus activated kinase (JAK) family [21]. In the case
of the IFN-γ receptor, the IFNGR1 subunit is associated
with JAK1, whereas IFNGR2 is associated with JAK2. The
first step in the IFN-γ mediated signalling is the acti-
vation of these receptor-associated JAKs after a ligand-
dependent modification and dimerisation of the receptor
subunits, followed by autophosphorylation and activation
of the specific JAKs, which then activate the classical
JAK/STAT (signal transducer and activator of transcrip-
tion) signalling pathways [22]. Following the stimulation
of the IFN-γ receptor and the phosphorylation of JAK,
what occurs is a dimerisation of STAT1, which binds as a
homodimer to cis regulatory elements known as “gamma-
activated sequences” (GAS) in the promoters of the genes
encoding NOS2, the Major Histocompatibility Complex
(MHC) class II transactivator (CIITA) and SOCS3 among
others [21, 23, 24].
The immunocompetence of macrophages regulated by
IFN-γ and JAK/STAT pathway corresponds to an increase
in IFN-γ production. These molecular components are
regulators of M1 polarisation, and they lead to the syn-
thesis of cytokines, nitric oxide, reactive oxygen inter-
mediates (ROI) and enzymes that participate in tissue
remodelling [25]. LPS is a component of Gram-negative
bacterial cell wall and induces the expression of a variety
of genes that drives the innate immune response to bacte-
rial infections. LPS signals through toll-like receptor TLR4
especially expressed on macrophages and neutrophils.
TLRs mediate the response to a variety of infectious
agents and facilitate induction of many pro-inflammatory
genes [26, 27]. Signalling through TLR4 induces rapid
activation of two distinct intracellular signalling path-
ways that mediate the activation of specific transcription
factors, such as NF-kB via the MyD88-dependent path-
way; these pathways converge to activate the transcrip-
tion of NOS2, the inducible NO synthase [28–30]. M2
macrophages exhibit a functionally distinct phenotype to
that of M1s, thanks to IL-4 and IL-13, which are able
to induce the mannose receptor (MR) expression, and
another cytokine, IL-10, that play a pivotal role in the M2
polarisation. It is well established that IL-4 is associated
with Th2 responses, which have well-defined effects on
macrophages, other cells and immune functions. IL-4 is a
cytokine producedmostly in allergic, cellular and humoral
responses to parasitic and extracellular pathogens. It
upregulates the expression of the mannose receptor and
MHC class II molecules by macrophages, which stimu-
lates endocytosis and antigen presentation, and induces
the expression of distinct chemokines [31]. IL-4 acts
through signal transducer and activator of transcription 6
(STAT6).
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Anti-inflammatory M2 subtype
IL-10 produced by B cells drives the macrophage to a
M2 phenotype. It acts on a distinct plasma-membrane
receptor to those for IL-4 and IL-13 [32], and its effects
on macrophage gene expression is different, involving
several inhibition and effector functions, together with
the activation and expression of distinct genes. IL-10
triggers a M2 macrophage polarisation with a charac-
teristic cytokine pattern of expression of IL-10hi, IL-
12lo, IL-23lo and TGFβ+, which is associated with anti-
inflammatory responses, immune regulation, tissue repair
and tumour promotion. IL-10 is able to suppress the
immune activation by down-regulating the expression of
MHC II and pro-inflammatory cytokines, thus affecting
M1-derived cytokines [33]. IL-10 is a potent signal trans-
ducer and activator of transcription 3 (STAT3)-dependent
inhibitor of pro-inflammatory cytokine production and
nitric oxide release. The upregulation of expression of
IL-4Rα (indicated IL-4Ra) by IL-10 is associated to
increased levels of arginase-1 (Arg1) derived from the IL-4
pathway.
Peroxisome proliferator-activated receptor γ (PPARγ
herein PPARg) is a master regulator of lipid metabolism in
macrophages and inhibits pro-inflammatory gene expres-
sion through several mechanisms, including the repres-
sion of NF-kB [34, 35]. PPARg is constitutively expressed
by adipose tissue macrophages, but its expression can also
be induced by IL-4 via STAT6, which indicates that M2
polarisation might also involve PPARγ . Indeed, a recent
study has shown an important role for STAT6 as a cofac-
tor in PPARγ -mediated gene regulation in vitro; therefore,
crosstalk between PPARγ and the IL-4/STAT6 axis might
coordinately control the M2 phenotype [23].
IL-4-induced macrophage polarisation also involves
Krüppel-like factor 4 (KLF4), which promotes M2 polar-
isation cooperating with STAT6 and blocking the M1
polarisation through the inhibition of NF-kB [36, 37].
Suppressor of cytokine signalling proteins (SOCS)
play an important role in regulating M1 and M2
macrophage polarisation. SOCS1, induced by STAT6,
promotes the M1 polarisation by inhibiting the
JAK2/STAT1 signalling, while SOSC3, induced by STAT1,
supports a pro-inflammatory phenotype inhibiting
STAT3 [38].
Given the knowledge reported above we established the
gene regulatory network (GRN) described in Fig. 1 and
Table 1.
Methods
Statistical ensemble of gene regulatory networks
In statistical mechanics, a statistical ensemble refers to
a large number (ideally infinite) of virtual copies of a
system, each of which represents a possible and real-
istic state of the actual system. An ensemble therefore
represents a probability distribution for the state of the
system [39].
We generated copies of the above-constructed gene
regulatory network of M1/M2 differentiation (i.e., the
“system”) to build a statistical ensemble in order to
calculate the probability distribution of the “state” of the
differentiating macrophage, and to describe how this state
changes with respect to biological stimuli such as bacterial
infections or others.
Since a macrophage taken in isolation from the other
immune cells and antigenic stimuli would not undergo any
differentiation, we also incorporated in the model other
cellular and molecular components so to have the main
signals needed to represent both possible M1 and M2
differentiation pathways. This inclusion fully implements
the mesoscopic (cell-cell interactions) of the model. The
intra-cellular microscopic gene regulation level and the
inter-cellular mesoscopic level, together constitute a mul-
tiscale system and enacts a full fledged adaptive immune
response.
It is worth to note that for simplicity the model con-
siders antigen-specific clonotypes of lymphocytes, i.e., it
does not implements a full clonal selection process with
antigen recognition.
In more details, we included in the ensemble virtual
copies of B-cells (indicated B), macrophages (M), T helper
lymphocytes (T), a generic antigen (Ag) bearing LPS as
membrane molecules and cytokines IFNg (IFNg), IL-10
(IL10) and IL-4 (IL4).
Macrophages are subdivided in the undifferentiated
phenotype (M0), in the terminally differentiated type-1
(indicatedM1) and type-2 (M2).
Helper T lymphocytes are further divided in type-
1 (indicated H1), type-2 (H2) and regulatory cells (Hr)
each of which secretes a different differentiation stim-
uli upon contact with the macrophage. Moreover, since
cytokines are secreted by cells in particular activation
states, we refined the representation of macrophages
and lymphocytes including this information. Hence we
defined macrophages in the resting (Mr), active (Ma)
and presenting state (Mp); helper lymphocytes (all three
classes 1, 2, r) in the resting (Hr1,2,r) and active (Ha1,2,r)
state; B lymphocytes in the active (Ba) and presenting
state (Bp). By “presenting” we mean that the antigen
presenting cell B or macrophage has captured, inter-
nalised, processed and presented the antigen on the cell
membrane together with the Major Histocompatibility
Complex molecule. This process is not further detailed
to keep the model simple. Table 2 contains a symbol
legend.
The so constructed mesoscopic cell interaction level
can be seen as a bioreactor in which each individual cell
undergoes state transformations according to predefined
immunologically-motivated rules [40]. Cells populate a
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Fig. 1 The gene regulatory network. A minimalistic gene regulatory networks of macrophage differentiation into the M1 and M2 subclasses.
Signalling stimuli are “sensed” by membrane receptors that activate genes through the regulatory circuitry. Also see Table 1
3D lattice where they freely diffuse and interact according
to stochastic rules of the form
αA + βB + · · · p−→ γG + δD + · · ·
meaning that the rule applied to α instances of A, β
instances of B etc. that are located in the same lattice site
will produce γ instances of G, δ instances of D etc. with
probability p.
The full list of rules is the following:
Mr + IFNg p1−→ Ma (1)
Ma + Ag p2−→ Mp (2)
Mp p3−→ Ma (3)
Ma p4−→ Mr (4)
Table 1 Nodes of the network
Input Receptor Internal nodes Phenotype References
LPS TLR4 NF-kB, NOS2 M1 [20–23, 25–30, 38]
IFNg IFNgR STAT1, SOCS3, NOS2 M1 [20–23, 25–30, 38]
IL-4 IL-4Ra STAT6, PPARg, M2 [23, 24, 31–38]
SOCS1, KLF4, Arg1
IL-10 IL-10R STAT3 M2 [23, 24, 31–38]
Internal nodes means transducers/transcription factors/target genes
Mp + Ha1
p5−→ Mp + Ha1 + IFNg (5)
Mp + Ha2
p6−→ Mp + Ha2 + IL4 (6)
Mp2 + Har
p7−→ Mp + Har + IL10 (7)
Ba + Ag p8−→ Bp (8)
Bp p9−→ Ba (9)
Bp + Ha1
p10−→ 2Bp + 2Ha1 + IFNg + Ab (10)
Bp + Ha2
p11−→ 2Bp + 2Ha1 + IL4 + Ab (11)
Hr1,2,r + Mp
p12−→ Ha1,2,r + Mp (12)
Table 2 Cell states
Cell type/state Symbol
Macrophage resting or inactive Mr
Macrophage active Ma
Macrophage presenting the antigen Mp
B-cell active Ba
B-cell presenting the antigen Bp
T-helper resting or inactive Hr
T-helper active Ha
M indicates both type-1 and -2 macrophages. Likewise H indicates type-1, -2 and
regulatory T hyper lymphocytes




p14−→ Ha1 + Bp + IFNg (14)
Ab + Ag p15−→ ∅ (15)
The first “reaction”, or rule R1 of Eq. (1), stands for
macrophage activation by IFNg.
R2 represents antigen phagocytation, digestion and pre-
sentation by macrophages.
R3 stands formacrophages stopping presenting the anti-
gen on cell surface.
R4 stands for macrophages returning to the resting
state.
R5 indicates macrophage presenting the antigen to
helper T cells of type-1 and inducing release of IFNg.
R6 is the same as before but for type-2 the released
cytokine is IL-4.
R7 likewise, upon contact with M2 cells, Treg lympho-
cytes release IL-10.
R8 is antigen phagocytation, digestion and presentation
by B-cells.
R9 stands for B-cells stopping presenting the antigen on
cell surface thus going back to the active state.
R10 is B-cells presenting the antigen to helper T cells of
type-1 and inducing release of IFNg as well as antibodies
(with the implicit assumption of B-cell differentiation to
plasma B cells secreting antibodies).
R11 is the same as before but for type-2 the released
cytokine is IL-4.
R12 antigen presenting macrophage activation of helper
T-cells.
R13 stands for helper T-cells going back to resting.
R14 is releasing of IFNg by class-1 T-helper upon recog-
nition of antigen peptides presented by B-cells.
R15 is the neutralisation of antigen by the antibodies.
These rules are executed in randomised order at each
simulation step (to avoid biases). In principle p should be
different for each rule, however, to keep the model simple
we set ∀i = 1, . . . , 15, pi = 1, that is, we allow all reactions
to take place whenever all the necessarymolecules aremet
on the same lattice point.
We can say that the ensemble consists of a Reactive
Lattice Gas Automata (RLGA) on a three-dimensional
cartesian lattice L × L × L with periodic boundary con-
ditions. At the start, a large number of copies of cells
populate the simulated volume. The relative proportion
of lymphocytes and monocytes is set as in the standard
human white blood cell counts [41]. Macrophages, that
are the only agents whose internal dynamics is fully spec-
ified by the network show in Fig. 1, are initialised with
the gene-state equal to zero meaning that the nodes of the
network are in the inactive form (see below)). The rules
R1–R15 (respectively Eq. (11)–(15)) are then applied in
each lattice point. After that, all entities diffuse randomly
on the lattice with equal speed. In this respect the lattice
represents a homogenous media and a lack of differences
in the diffusion speed of the various cells and molecules
does not affect the “logic” of the model, which is what we
are more interested in studying.
The rule for macrophage differentiation
The last rules of the mesoscopic model implements the
differentiation of the macrophages from the undifferen-
tiated M0 phenotype to either M1 or M2. They realise
the connection between the two levels of the multiscale
description of the model.
As already mentioned, the networks in the ensemble are
initialised as x¯0 = 0¯, that is, all genes are not expressed in
the initially populating phenotypeM0. The differentiation





where the macrophage has to be either active (superscript
a) or presenting (superscript p) and the f1 and f2 are two
probability functions defined as follows
f1≡
{
1, S(x¯t ∧ I, k)=X1
0, otherwise f2 ≡
{
1, S(x¯t ∧ I, k) = X2
0, otherwise
with
S(x¯t ∧ I, k) = F ◦ F ◦ · · · ◦ F︸ ︷︷ ︸
k
(x¯t ∧ I).
Thus, if the network state attained after k synchronous
application of the Boolean dynamics F(·) reaches an
attractor X1 or X2, then the macrophage is considered
committed, that is, terminally differentiated to the type-
1 or type-2. Otherwise the state remains x¯t+k and the
macrophages is still undifferentiated (i.e., M0). Specif-
ically, S(x¯t ∧ I, k) is the state of the network after k
application of the function F(·) starting from x¯t and
after the input nodes have been updated with I =
(IFNg, IL10, IL4, LPS) where LPS here means Ag with LPS
on its surfacemembrane. In other words x¯t∧I is the vector
x¯t with the values corresponding to IFNg, IL10, LPS and
IL4 updated with the values in I (see extracellular stimuli
layer in Fig. 1). Now if
∀k > 0, k ∈ N, S(x¯t ∧ I, k) = x¯t ∧ I
this means that the dynamics has converged to a fixed
point. We call X1 the fixed point associated to the phe-
notype M1 and X2 the fixed point associated to the phe-
notype M2. By construction X1 = X2 and therefore it
follows that in rules R16 and R17 (respectively in Eqs. (16)
and (17)) it must be that at any time f1 + f2 ≤ 1 (i.e.,
none or only one of the two steady state is reached). In
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other words, each network of the ensemble representing a
macrophage initially in the undifferentiated state has the
chance to differentiate at each discrete step on the basis of
its current state x¯t and the input I, which in turn is given
by the local (i.e., in the same lattice site) “concentration” of
IFNg, IL10, IL4 and antigen with LPS in the current lattice
location (the lattice location has not been indicated in the
formalism above for simplicity).
Results and discussion
Ensemble dynamics
Here we describe what we obtained when we challenged
the system with different stimuli driving the differential
polarisation of macrophages. To show it, we have identi-
fied a couple of situations in which there is experimental
evidence about polarisation in one or the opposite direc-
tion, and verified that the in silico model is in agreement
with those. The two cases are described below.
M1 polarisation
We obtain a pro-inflammatory response if we challenge
the system with an LPS-carrying (i.e., Gram-negative)
bacterium. In this case a clear M1 polarisation is shown
in Fig. 2 (more details can be found in the figure caption).
This is in agreement with [12, 13] and represents the pri-
mary pro-inflammatory function of macrophages during
bacterial infections.
M2 polarisation
IL-4 drives the macrophage to a M2 phenotype, involv-
ing both innate and adaptive immune system cells. IL-4
is secreted during Th2 immune responses, after a dis-
turbance at mucosal surfaces, especially in lung and
intestines, or after fungi or helmint infections [42].
Indeed, in vitro experiments onmacrophages treated with
IL-4, showed a decreased production of pro-inflammatory
cytokines and oxygen radicals [43]. Furthermore, baso-
phils and mast cells are important early sources of IL-4,
which is produced as one of the first innate signals to be
released after injury, and in response to chitin, a typical
product of fungi and parasites. As a result, an increasing
of the wound healing macrophage population is observed,
switching towards a M2-like phenotype, with the pro-
duction of aginase and other typical anti-inflammatory
molecules, and the secretion of extracellular matrix com-
ponents [23].
In our model, when the systems is challenged with
a simple vaccine which does not carry LPS membrane
molecules but, after a short while (after 3 days and for a
whole week) the pro-M2 cytokines IL-4 is injected (sim-
ulating basophils and mast cells contribution), an M2
polarisation is obtained (this is shown in Fig. 3).
IL-10 is a cytokine produced by all leukocytes, includ-
ing macrophages, dendritic cells, natural killer cells, neu-
trophils, eosinophils, mast cells, B cells, and some T-cell
Fig. 2M1-polarised response. Challenging the system with a Gram-negative bacteria the system responds with a M1/H1 polarised immune
response. The top-left panel shows bacterial growth and antibody production; top-right panel shows production of IFNg cytokines as well as to a
smaller extend IL-4 and no IL-10; bottom-left panel shows polarisation of helper T-cells to H1; bottom-right panel shows polarisation of macrophages
toward theM1 phenotype
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Fig. 3M2-polarised response. Here the system is challenged by a vaccine which does not include LPS as adjuvant (e.g., inactive gram positive
bacteria). After a short while (after 3 days and for a whole week) we also inject the pro-M2 cytokines IL-4. In this case the M2-polarisation is shown in
the bottom right panel, followed by a polarisation of T-helpers toward the H2 phenotype
populations. In macrophages, it acts as a potent anti-
inflammatory molecule, playing a pivotal role in limiting
immune-mediated pathology. In helminth infections,
macrophages are an important source of IL-10. When
produced by regulatory T cells, IL-10 determines the
polarisation of regulatory macrophages, which act as
antigen-presenting cells, produce IL-10 and can induce
the expansion of Th2 cells. IL-10 is a potent downreg-
ulator of macrophage gene expression, modulating IL-4
and IL-13 and IFNg actions. Indeed, IL-10 has actions on
macrophages that are clearly distinct from those of IL-4
and IL-13, which reflects the pattern of gene expression of
IL-10-stimulated macrophages [11, 31, 43–45]
On the basis of what just reported, another possibility
to trigger an M2 immune response in the computational
model is to inject a bacterium (with LPS) followed by an
injection of IL-10. This situation mimics the case in which
IL-10 comes from sources other than macrophages, as
for instance in allergies mediated through IgE signalling
which triggers mast cell degranulation and release of IL-
10 [46]. Indeed, many forms of cutaneous and mucosal
hypersensitivity reactions are mediated in large part by
Fig. 4M2-polarised response. The effect of injecting IL-10 after a bacterial infection is clearly shown is panel a in two representative cases of
possible outcome; in some cases (43% of total stochastic simulations performed) IL-10 dampens the immune response. Panel b shows the average
population kinetics of the two macrophage sub-types as well as the injected IL-10 concentration (error-bars show standard deviation over a number
of stochastic simulations). This plot demomstrates that IL-10 downregulates immune reponse by promoting M2 differentiation. Similarly, panel c
shows T-helper cell sub-types
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mast cells. They play a central role in asthma, eczema,
itch (from various causes), and allergic rhinitis and allergic
conjunctivitis.
In this case in the model the initial H1/M1 response
shifts toward an M2 response which is ineffective com-
pared to the previous as witnessed by the fact that the
bacterium continues to grow rather being controlled (see
Fig. 4 and caption for details).
Conclusions
Macrophages play critical functions in the immune
response development, homeostasis, tissue repair and
immunity. Accordingly, a number of disorders in humans
and mice have been related to deregulated macrophage
differentiation process and cell function (e.g., leishmani-
asis, neoplastic diseases, asthma and respiratory diseases,
neuropathies, stroke, among others) [47]. The complex-
ity and plasticity of the macrophage differentiation only
recently have gained much appreciation.
Here we implemented a multiscale computational
approach to simulate macrophage differentiation in which
two different level of description, i.e., gene regulation and
cell population dynamics are combined into a complex
immune system model.
The model described here does not focus on a spe-
cific disease nor it encompasses pathogen-specific pro-
cesses such as virus mutation or tumor escape for which
a more detailed description of the immunological pro-
cesses would be required as in the model described in
[9, 10]. It shows however how such model integration
allows bridging a gap between gene level information and
cell level population by testing the model to reproduce
behaviour qualitatively coherent with experimental data
when exposed to different immunological challenges.
In our former work, we introduced Th1/Th2/Th17/Treg
differentiation [9] in an integrated agent-based immune
system model, further steps toward the enhancement of
the integrated model will concern the merging and fine
tuning of such different cell types combined dynamics.
Themacrophage differentiation network presented here
is minimalistic, although coherent with respect to the
dynamics shown hence there is no reason to resort to
stability analysis or other methods to understand its
dynamical properties. We are currently constructing an
enlarged version of the network with the aim of per-
forming more detailed and extensive simulations includ-
ing stability analysis and perturbation experiments such
as knockouts and ectopic expressions, to see how they
affect the network functionality. This work will proceed
along the line of the method described in this article with
the hope to better understand the complex role of the
macrophages in the elicitation of the adaptive immune
response.
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